These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 20471883

  • 1. Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies.
    Chong Y, Yakushiji H, Ito Y, Kamimura T.
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e171-5. PubMed ID: 20471883
    [Abstract] [Full Text] [Related]

  • 2. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D, Gülay Z, Akan OA, Aktaş Z, Kayacan CB, Cakici O, Eraç B, Gültekin M, Oğünç D, Söyletir G, Unal N, Uysal S.
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [Abstract] [Full Text] [Related]

  • 3. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R, Estaitieh N, Mugharbil A, Jisr T, Abdallah DI, Ziade F, Sinno L, Ibrahim A.
    Front Cell Infect Microbiol; 2015 Oct; 5():11. PubMed ID: 25729741
    [Abstract] [Full Text] [Related]

  • 4. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
    Paul M, Gafter-Gvili A, Leibovici L, Bishara J, Levy I, Yaniv I, Shalit I, Samra Z, Pitlik S, Konigsberger H, Weinberger M.
    Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
    [Abstract] [Full Text] [Related]

  • 5. Failure of cefepime therapy in neutropenic patients with extended-spectrum beta-lactamase-producing Gram-negative bacteraemia.
    Wi YM, Kang CI, Cheong HS, Chung DR, Jung CW, Ko KS, Song JH, Peck KR.
    Int J Antimicrob Agents; 2009 Apr; 33(4):384-6. PubMed ID: 19097866
    [No Abstract] [Full Text] [Related]

  • 6. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
    Chee L, Brown M, Sasadeusz J, MacGregor L, Grigg AP.
    J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
    [Abstract] [Full Text] [Related]

  • 7. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P, Hasçelik G, Unal S.
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [Abstract] [Full Text] [Related]

  • 8. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, Musser JM.
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [Abstract] [Full Text] [Related]

  • 9. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia.
    Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang SC, Hsueh PR.
    Epidemiol Infect; 2010 Jul; 138(7):1044-51. PubMed ID: 19941686
    [Abstract] [Full Text] [Related]

  • 10. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
    Marin M, Gudiol C, Ardanuy C, Garcia-Vidal C, Calvo M, Arnan M, Carratalà J.
    J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
    [Abstract] [Full Text] [Related]

  • 11. Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia.
    Song W, Moland ES, Hanson ND, Lewis JS, Jorgensen JH, Thomson KS.
    J Clin Microbiol; 2005 Sep; 43(9):4891-4. PubMed ID: 16145169
    [Abstract] [Full Text] [Related]

  • 12. Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
    Chong Y, Shimoda S, Yakushiji H, Ito Y, Miyamoto T, Kamimura T, Shimono N, Akashi K.
    PLoS One; 2013 Sep; 8(1):e54190. PubMed ID: 23372683
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
    Kara Ö, Zarakolu P, Aşçioğlu S, Etgül S, Uz B, Büyükaşik Y, Akova M.
    Infect Dis (Lond); 2015 Sep; 47(10):686-93. PubMed ID: 26024284
    [Abstract] [Full Text] [Related]

  • 14. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
    Chong Y, Yakushiji H, Ito Y, Kamimura T.
    Int J Infect Dis; 2011 Apr; 15(4):e277-81. PubMed ID: 21324723
    [Abstract] [Full Text] [Related]

  • 15. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
    Cordero L, Rau R, Taylor D, Ayers LW.
    Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
    [Abstract] [Full Text] [Related]

  • 16. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Polwichai P, Trakulsomboon S, Dejsirilert S, Thongmali O, Sawanpanyalert P, Aswapokee N, Buppanharun W.
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF, Bulitta J, Lipman J, Kirkpatrick CM.
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [Abstract] [Full Text] [Related]

  • 18. Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Labombardi VJ, Rojtman A, Tran K.
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):313-5. PubMed ID: 17084784
    [Abstract] [Full Text] [Related]

  • 19. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M, Vera DE, Ramírez-Ronda CH, Saavedra S.
    P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
    [Abstract] [Full Text] [Related]

  • 20. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K.
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.